Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
opløsning 5 %
DRUG
2 trials
Sponsors
CSL Behring LLC
, Rigshospitalet
Conditions
Acute critical illness requiring intensive care unit admission.
Post-COVID-19 Postural Orthostatic Tachycardia Syndrome
Phase 3
Double-blind, Randomized, Placebo-controlled Phase 3 study Evaluating Efficacy and Safety of IgPro20 (subcutaneous immunoglobulin, HIZENTRA®) in post-COVID-19 Postural Orthostatic Tachycardia Syndrome (POTS)
Completed
CTIS2023-508744-22-00
CSL Behring LLC
Post-COVID-19 Postural Orthostatic Tachycardia Syndrome
End: 2025-05-13
Target: 17
Updated: 2025-05-08
Phase 4
The Intensive Care Platform Trial (INCEPT)
Recruiting
CTIS2024-516208-41-00
Rigshospitalet
Acute critical illness requiring intensive care unit admission.
Start: 2025-06-26
Target: 20000
Updated: 2025-12-22